despit
advanc
pcrbase
assay
avail
fraction
pediatr
respiratori
infect
remain
unexplain
everi
epidem
season
percept
novel
virus
might
present
specimen
systemat
collect
sampl
prospect
cohort
pediatr
patient
respiratori
infect
return
neg
result
valid
molecular
rtpcr
assay
studi
targetindepend
highthroughput
sequencingbas
approach
also
includ
match
cohort
children
symptom
respiratori
infect
contrast
studi
popul
fifti
percent
specimen
group
patient
unexplain
respiratori
infect
resolv
howev
higher
rate
detect
due
presenc
novel
virus
identif
wellknown
viral
respiratori
pathogen
result
show
alreadi
known
viral
pathogen
respons
major
case
remain
unexplain
epidem
season
highthroughput
sequenc
approach
use
pathogenspecif
probe
easier
standard
ensur
reproduc
librari
enrich
sequenc
consequ
techniqu
might
desir
regulatori
standpoint
diagnost
laboratori
seek
benefit
mani
advantag
sequenc
technolog
rate
discoveri
new
microb
new
associ
microb
health
diseas
acceler
significantli
last
decad
mani
factor
contribut
phenomenon
includ
favour
true
emerg
new
pathogen
well
new
technolog
paradigm
enabl
detect
character
popular
media
focus
attent
biodefens
emerg
infecti
diseas
provid
foundat
unpreced
support
basic
translat
research
host
vector
microb
biolog
well
diagnost
surveil
new
molecular
technolog
base
highthroughput
sequenc
ht
facilit
discoveri
appreci
emerg
infecti
diseas
repres
zoonos
also
impact
moreov
databas
need
recogn
microbi
sequenc
improv
dramat
develop
sophist
algorithm
search
identif
thu
current
accept
vision
posit
tackl
effect
problem
detect
unknown
known
eg
unexpect
rare
pathogen
true
reliabl
agnost
pathogen
discoveri
detect
unknown
unknown
eg
true
novel
pathogen
still
art
accord
latest
global
health
estim
world
health
organ
respiratori
infect
among
five
lead
caus
death
worldwid
caus
near
million
death
acut
respiratori
infect
ari
account
death
children
less
year
age
industri
countri
death
develop
countri
ari
viral
origin
one
main
caus
hospit
among
patient
typic
suffer
one
episod
season
despit
advanc
signific
proport
pediatr
ari
remain
without
caus
agent
everi
epidem
season
fact
exclus
ari
case
viral
enceph
near
death
gastroenter
foodborn
diseas
remain
unassign
specif
pathogen
even
syndrom
laboratori
test
although
multipl
reason
explain
result
relat
diagnost
technolog
failur
eg
noninfecti
caus
inadequ
late
investig
sampl
percept
pathogen
lurk
undetect
specimen
widespread
unfortun
comprehens
risk
assess
threat
perform
yet
report
perform
systemat
studi
respiratori
specimen
collect
care
character
highli
repres
prospect
cohort
pediatr
case
suffer
unexplain
ari
compar
rate
detect
pathogen
util
valid
molecular
assay
comprehens
sequenceindepend
highthroughput
sequencingbas
analysi
order
assess
clinic
relev
viral
identif
made
ht
specimen
collect
unexplain
case
respiratori
infect
second
cohort
agematch
healthi
individu
epidemiolog
environ
also
studi
methodolog
septemb
june
children
year
age
respiratori
tract
diseas
admit
severo
ochoa
hospit
madrid
spain
evalu
attend
physician
clinic
data
record
includ
age
gender
gestat
age
less
week
clinic
diagnosi
need
length
oxygen
therapi
axillari
temperatur
durat
fever
total
white
blood
cell
count
creactiv
protein
serum
level
presenc
infiltrateatelectasi
chest
xray
administr
antibiot
therapi
hospit
stay
inclus
pediatr
intens
care
unit
upper
respiratori
tract
infect
urti
diagnos
rhinorrhea
andor
cough
found
without
fever
absenc
wheez
dyspnea
crackl
rale
bronchodil
use
asthma
diagnos
basi
nation
asthma
educ
prevent
program
guidelin
naepp
retriev
http
wwwnhlbinih
govfilesdocsguidelinesasthmafullrptarchivepdf
acut
expiratori
wheez
consid
bronchiol
occur
first
time
children
year
episod
acut
expiratori
wheez
consid
wheez
episod
case
consid
pneumonia
focal
infiltr
consolid
chest
xray
detect
case
appar
lifethreaten
event
alt
defin
episod
frighten
observ
character
combin
apnea
colour
chang
mark
chang
muscl
tone
choke
gag
fever
without
sourc
fw
diagnos
otherwis
healthi
child
month
age
present
fever
less
day
durat
altern
infecti
etiolog
rule
nasopharyng
aspir
npa
systemat
taken
patient
analys
multiplex
realtim
rtpcr
base
previous
publish
method
assay
allow
detect
main
viral
respiratori
pathogen
includ
influenza
viru
b
c
human
rhinoviru
enteroviru
human
orthopneumoviru
human
respiratori
syncyti
viru
human
bocaviru
human
metapneumoviru
adenoviru
human
rubulaviru
human
parainfluenza
viru
human
coronaviru
fiftyseven
npa
age
rang
month
year
old
femal
male
gave
neg
result
assay
includ
present
studi
clinic
present
patient
refer
text
case
group
describ
tabl
second
group
npa
taken
prospect
cohort
agematch
healthi
donor
includ
control
refer
text
control
group
individu
includ
control
group
children
visit
hospit
caus
eg
food
allergi
test
histori
respiratori
infect
day
day
visit
patient
came
geograph
area
patient
respiratori
tract
diseas
npa
collect
period
time
cover
epidem
season
viru
circul
analys
molecular
assay
describ
alway
result
neg
studi
approv
medic
ethic
committe
instituto
de
salud
carlo
iii
cei
pi
inform
written
consent
obtain
particip
viru
identif
targetagnost
highthroughput
sequenc
analysi
respiratori
specimen
includ
studi
process
sequenc
individu
npa
homogen
pass
sampl
ml
steril
syring
needl
becton
dickinson
new
jersey
usa
vortex
centrifug
min
room
temperatur
filter
pores
filter
ultrafreemc
millipor
massachusett
usa
filtrat
process
rneasi
micro
kit
qiagen
maryland
usa
perform
oncolumn
dna
digest
follow
manufactur
protocol
rna
extract
amplifi
sispa
rtpcr
describ
previous
amplif
product
purifi
minelut
pcr
purif
kit
qiagen
shear
use
covari
instrument
tabl
data
analysi
perform
follow
cutadapt
prinseqlit
picard
http
broadinstitutegithubiopicard
use
remov
adaptor
primer
pcr
duplic
qualiti
filter
index
phred
read
phred
remov
read
belong
host
perform
align
qualitytrim
read
human
genom
refer
http
www
ncbinlmnihgovgenomeguidehuman
host
remov
step
read
subject
de
novo
assembl
use
ray
assembl
contig
bp
taxonom
identifi
sequenc
similar
nucleotid
collect
nrnt
databas
genbank
use
ncbi
blast
megablast
dcmegablast
evalu
threshold
contig
match
analys
orffind
http
wwwncbinlmnihgovorffind
identifi
orf
compar
nonredund
protein
sequenc
nr
databas
genbank
blastx
analysi
evalu
threshold
unmap
read
align
nr
databas
genbank
diamond
use
sensit
mode
neg
control
consist
steril
rnasefre
water
process
parallel
respiratori
specimen
hit
identifi
neg
control
consid
laboratori
contamin
report
suplemmentari
method
result
blastn
blastx
analysi
manual
curat
contig
back
read
pair
mate
well
match
repeatedli
low
complex
genom
region
endogen
integr
viral
sequenc
discard
sequenc
data
gener
studi
deposit
ncbi
sra
databas
bioproject
number
npa
specimen
contain
read
respiratori
viru
analys
rtpcr
order
confirm
result
ht
analysi
primer
pair
design
viral
nucleotid
sequenc
inform
obtain
ht
analysi
supplementari
tabl
rtpcr
perform
rna
extract
initi
use
ht
analysi
assay
perform
agpathid
onestep
rtpcr
kit
thermofish
scientif
massachusett
usa
follow
manufactur
protocol
amplif
condit
follow
min
min
cycl
min
follow
final
extens
step
min
rtpcr
product
analys
agaros
gel
electrophoresi
purifi
minelut
pcr
product
purif
kit
qiagen
sequenc
bigdy
termin
cycl
sequenc
kit
life
technolog
california
usa
targetagnost
ht
analysi
nasopharyng
aspir
taken
case
group
produc
total
million
read
contig
taxonom
identifi
blastn
analysi
figur
total
contig
million
read
identifi
blastn
analysi
sampl
taken
control
group
figur
b
case
group
contig
assign
virus
repres
contig
virus
repres
contig
control
group
figur
b
among
contig
assign
virus
case
group
contig
million
read
map
correspond
virus
infect
eukaryot
organ
contig
million
read
map
correspond
bacteriophag
among
contig
assign
virus
infect
eukaryot
organ
differ
famili
identifi
name
papillomavirida
pneumovirida
picornavirida
paramyxovirida
anellovirida
coronavirida
circovirida
orthomyxovirida
polyomavirida
figur
c
altogeth
number
contig
assign
respiratori
viral
pathogen
account
contig
tabl
take
account
number
read
vast
major
million
read
map
contig
assign
respiratori
viral
pathogen
tabl
among
human
orthopneumoviru
human
respiratori
syncyti
viru
hrsv
human
rhinoviru
hrv
frequent
tabl
altogeth
least
one
respiratori
viral
pathogen
could
identifi
targetagnost
ht
analysi
npa
specimen
virus
identifi
sampl
includ
sapeloviru
human
parechoviru
human
papillomaviru
hpv
human
circular
viru
torqu
teno
viru
torqu
teno
mini
viru
human
polyomaviru
wu
polyomaviru
tabl
respiratori
specimen
taken
control
group
contig
contig
read
map
correspond
virus
infect
eukaryot
organ
contig
million
read
map
correspond
bacteriophag
among
contig
assign
virus
infect
eukaryot
organ
member
papillomavirida
circovirida
pneumovirida
anellovirida
picornavirida
herpesvirida
totivirida
virgavirida
reovirida
identifi
figur
viral
respiratori
pathogen
identifi
two
specimen
one
produc
contig
identifi
hmpv
vast
major
read
map
read
tabl
second
specimen
hrv
identifi
contig
read
map
remain
read
map
total
contig
identifi
follow
virus
hpv
human
circular
viru
torqu
teno
viru
red
clover
powderi
mildew
associ
totiviru
tobacco
mosaic
viru
rotaviru
human
betaherpesviru
tabl
result
contigspecif
rtpcr
assay
confirm
targetagnost
ht
analysi
case
group
hrsv
hrv
preval
virus
follow
ev
hpiv
hcov
influenza
b
viru
hmpv
tabl
control
group
two
npa
hmpv
hrv
identifi
ht
analysi
confirm
posit
virus
tabl
sever
specimen
among
case
group
contain
one
viru
tabl
among
coinfect
hrsv
detect
either
hpiv
ev
hrv
hcov
detect
along
hrv
tabl
coinfect
detect
control
group
npa
taken
case
respiratori
infect
targetagnost
ht
analysi
identifi
known
respiratori
viral
pathogen
tabl
sampl
bacteriophag
torqu
teno
viru
hpv
human
circular
viru
human
polyomaviru
wu
polyomaviru
identifi
tabl
analysi
unidentifi
contig
assembl
sampl
look
sequenc
homolog
known
viral
protein
blastx
return
signif
result
although
hit
viral
protein
identifi
contig
map
also
protein
sequenc
genbank
databas
evalu
compar
rang
coverag
ident
percentag
valu
thu
could
consid
viralspecif
hit
repres
exampl
kind
identif
shown
tabl
read
form
contig
map
nr
genbank
databas
diamond
analysi
show
read
match
protein
bacteri
human
origin
belong
bacteriophag
put
novel
viru
identifi
result
shown
compar
bacteri
hit
identifi
targetagnost
ht
analysi
sampl
identifi
specimen
taken
control
group
sever
contig
identifi
blastn
analysi
wellrecogn
bacteri
respiratori
pathogen
streptococcu
pneumonia
haemophilu
influenza
klebsiella
pneumonia
howev
hit
bacteri
respiratori
pathogen
exclus
specimen
taken
case
respiratori
infect
could
identifi
also
specimen
taken
control
group
result
shown
sinc
analysi
design
quantit
conclus
regard
frequenc
could
made
test
multiplex
realtim
rtpcr
total
specimen
pediatr
respiratori
infect
remain
neg
analysi
differ
molecular
assay
order
shed
light
etiolog
infect
specimen
subject
targetindepend
ht
analysi
along
age
tabl
respiratori
viral
pathogen
identifi
targetagnost
ht
analysi
confirm
contigspecif
molecular
assay
respiratori
specimen
case
respiratori
infect
control
group
match
specimen
control
group
similarli
specimen
respiratori
infect
specimen
control
group
result
neg
aforement
molecular
assay
upon
ht
analysi
identifi
known
viral
respiratori
pathogen
hrsv
hrv
ev
hpiv
hcov
hmpv
influenza
b
viru
altogeth
least
one
respiratori
viral
pathogen
could
identifi
npa
specimen
group
respiratori
infect
contrast
control
group
sampl
contain
contig
attribut
viral
respiratori
pathogen
hmpv
hrv
moreov
hmpv
contig
detect
one
sampl
hoard
vast
major
read
assign
eukaryot
viru
remain
viral
entiti
anellovirus
papillomavirus
common
group
identif
respiratori
virus
ht
confirm
contigspecif
rtpcr
analysi
hmpv
hrv
identifi
control
group
occur
two
case
show
symptom
respiratori
diseas
asymptomat
infect
hrv
previous
report
frequent
young
children
although
asymptomat
infect
hmpv
occur
pediatr
stage
frequent
immunocompet
adult
individu
apart
common
respiratori
viral
pathogen
human
parechoviru
human
polyomaviru
wu
polyomaviru
identifi
ht
analysi
virus
identifi
specimen
group
respiratori
infect
sampl
none
control
group
detect
surpris
viru
frequent
caus
infect
childhood
caus
mild
gastrointestin
respiratori
diseas
human
polyomaviru
wu
polyomaviru
origin
detect
respiratori
secret
pediatr
patient
diagnos
pneumonia
unknown
origin
patient
acut
respiratori
coinfect
nonetheless
subsequ
larger
studi
found
link
wu
polyomaviru
acut
respiratori
diseas
studi
wu
polyomaviru
identifi
one
case
respiratori
infect
although
respiratori
viru
identifi
sampl
wu
polyomaviru
present
low
preval
case
respiratori
infect
high
rate
coinfect
common
respiratori
viral
pathogen
studi
need
ascertain
clinic
signific
thu
remain
unexplain
virolog
standpoint
known
respiratori
novel
viru
identifi
analysi
blastn
return
match
anellovirus
papillomavirus
tabl
repres
exampl
match
genbank
identifi
blastx
analysi
contig
remain
unassign
taxon
blastn
analysi
human
circular
viru
spite
thorough
indepth
analysi
contig
match
well
unmap
read
viral
match
genbank
databas
obtain
anellovirus
frequent
detect
tissu
organ
includ
respiratori
tract
healthi
individu
associ
diseas
human
papillomavirus
common
worldwid
infect
asymptomat
resolv
spontan
apart
common
wart
variou
type
cancer
includ
oropharyng
form
associ
infect
hpv
lowrisk
type
predomin
caus
respiratori
papillomatosi
diseas
noncancer
tumour
grow
air
passag
respiratori
tract
howev
oropharyng
cancer
respiratori
papillomatosi
evid
associ
papillomaviru
infect
respiratori
diseas
addit
lack
evid
associ
respiratori
diseas
studi
anellovirus
hpv
also
identifi
control
group
strengthen
conclus
presenc
relat
respiratori
diseas
human
circular
viru
recent
identifi
respiratori
secret
unexplain
human
case
febril
ill
although
associ
diseas
determin
small
circular
singl
strand
repencod
dna
cressdna
virus
increasingli
identifi
metagenom
ht
techniqu
environment
sampl
varieti
vertebr
well
variou
invertebr
human
report
fece
healthi
individu
sampl
unexplain
case
enceph
diarrhea
pericard
acut
central
nervou
system
infect
well
npa
children
respiratori
infect
howev
neither
studi
could
establish
direct
associ
diseas
thu
clear
valu
find
contig
match
viru
specimen
group
respiratori
infect
studi
need
determin
role
human
respiratori
diseas
find
agre
previou
studi
similar
design
tool
xu
et
al
employ
ht
analys
set
respiratori
specimen
taken
children
communityacquir
pneumonia
return
neg
result
commerci
respiratori
viral
panel
detect
assay
also
identifi
hpiv
torqu
teno
viru
torqu
teno
miniviru
wu
polyomaviru
zhou
et
al
studi
cellcultur
supernat
appar
cytopath
effect
prepar
undiagnos
respiratori
specimen
identifi
high
preval
ev
accompani
hrv
hrsv
hpiv
adv
influenza
c
viru
herpesviru
dengu
viru
taboada
et
al
studi
nasal
wash
children
respiratori
infect
previous
found
neg
common
bacteri
viral
respiratori
pathogen
pcr
identifi
least
one
known
respiratori
viru
includ
hrsv
hcov
hrv
vast
major
specimen
neither
studi
reveal
presenc
put
novel
viru
undiagnos
respiratori
infect
subject
studi
larg
major
case
could
attribut
known
viral
respiratori
pathogen
studi
suggest
respiratori
viral
pathogen
clinic
relev
pediatr
stage
alreadi
identifi
studi
analys
case
total
neg
pathogenspecif
pcr
assay
consequ
respiratori
specimen
collect
entir
epidem
season
remain
without
known
etiolog
infect
use
pathogentarget
diagnost
techniqu
targetindepend
ht
analysi
allow
us
come
specif
diagnost
half
undiagnos
infect
addit
resolv
case
produc
known
respiratori
pathogen
result
conclud
current
pathogenspecif
techniqu
abl
diagnos
vast
major
respiratori
infect
consequ
conclud
risk
overlook
novel
unknown
viral
respiratori
pathogen
pediatr
popul
low
use
targetspecif
diagnost
method
littl
valu
use
targetindepend
assay
routin
virolog
surveil
base
targetspecif
techniqu
realtim
rt
pcr
target
enrich
ht
approach
use
probe
specif
design
viral
genom
sequenc
interest
order
enrich
specif
sequenc
librari
deriv
said
viru
appropri
constitut
firstlin
diagnost
tool
question
etiolog
behind
case
respiratori
infect
remain
neg
routin
diagnost
assay
previous
address
sever
group
although
studi
use
overal
approach
similar
previou
studi
introduc
sever
improv
specif
studi
design
order
address
differ
limit
previou
work
identif
viral
read
clinic
specimen
remain
controversi
necessari
impli
virus
respons
symptom
observ
mani
virus
caus
asymptomat
subclin
infect
simpli
present
among
normal
healthi
microbiota
replic
without
pathogen
consequ
hinder
interpret
understand
result
unveil
viru
discoveri
studi
base
ht
regard
clinic
signific
studi
includ
contrast
studi
popul
control
group
form
prospect
cohort
healthi
individu
healthi
control
group
match
critic
level
cohort
patient
unexplain
infect
respiratori
tract
individu
control
group
agematch
ii
came
geograph
area
iii
sampl
also
taken
systemat
time
window
cover
epidem
season
viru
circul
includ
control
group
abl
determin
virus
detect
clinic
specimen
taken
patient
infect
respiratori
tract
circul
among
healthi
popul
provid
evid
virus
respons
respiratori
diseas
observ
case
would
acquir
special
import
novel
viral
entiti
previou
inform
avail
detect
summari
inclus
healthi
control
group
allow
us
assess
clinic
relev
virus
identifi
sampl
taken
case
unexplain
respiratori
infect
whenev
possibl
futur
viral
discoveri
studi
includ
match
healthi
control
group
virus
identifi
ht
patient
clinic
diseas
contrast
addit
inclus
match
healthi
control
group
process
sequenc
parallel
neg
control
consist
steril
nucleasefre
water
see
materi
method
section
confirm
viral
identif
made
ht
specif
rtpcr
assay
object
procedur
minim
chanc
report
fals
viral
identif
worth
highlight
also
perform
systemat
sampl
studi
group
sampl
collect
children
arriv
consecut
hospit
period
studi
whose
parent
legal
guardian
gave
explicit
written
consent
accord
preestablish
clinic
medic
criteria
see
materi
method
section
select
combin
procedur
discuss
studi
design
constitut
novel
integr
approach
ensur
robust
repres
result
minim
possibl
bia
provid
better
understand
clinic
implic
viral
identif
made
ht
analysi
ht
superior
overal
rate
detect
pathogen
due
presenc
cohort
unknown
pathogen
mostli
underperform
molecular
method
realtim
rtpcr
target
pathogen
virus
addit
identifi
ht
studi
wellknown
respiratori
pathogen
novel
virus
detect
altogeth
result
show
alreadi
known
viral
respiratori
pathogen
play
main
etiolog
role
behind
unexplain
case
respiratori
infect
pediatr
popul
signific
find
extrapol
clinic
syndrom
specimen
might
allow
us
quantit
assess
risk
new
paradigm
agnost
technolog
would
still
role
pathogen
detect
outbreak
event
situat
true
unknown
unknown
suspect
target
approach
would
becom
desir
nextgener
sequencingbas
microbi
diagnost
paradigm
might
desir
regulatori
standpoint
diagnost
laboratori
seek
incorpor
technolog
sinc
target
approach
allow
specif
reproduc
librari
enrich
thu
easier
assess
valid
